- Report
- June 2026
- 140 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- May 2026
- 350 Pages
Global
From €4506EUR$4,949USD£3,865GBP
- Report
- January 2026
- 150 Pages
Global
From €3596EUR$3,950USD£3,085GBP
- Report
- August 2026
- 160 Pages
Global
From €3023EUR$3,320USD£2,593GBP
€3779EUR$4,150USD£3,241GBP
- Report
- September 2026
- 199 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 193 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 198 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 189 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 191 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 281 Pages
Global
From €5326EUR$5,850USD£4,569GBP
- Report
- September 2026
- 364 Pages
Global
From €5326EUR$5,850USD£4,569GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,507GBP
- Report
- May 2026
- 180 Pages
Global
From €4097EUR$4,500USD£3,515GBP
- Clinical Trials
- May 2026
- 80 Pages
Global
From €1821EUR$2,000USD£1,562GBP
- Report
- May 2026
- 200 Pages
Global
From €2539EUR$2,789USD£2,178GBP
- Report
- March 2026
- 200 Pages
Global
From €2539EUR$2,789USD£2,178GBP
- Report
- August 2026
- 112 Pages
Global
From €4325EUR$4,750USD£3,710GBP
- Report
- January 2026
- 148 Pages
Global
From €3596EUR$3,950USD£3,085GBP
- Report
- October 2025
- 150 Pages
Global
From €4416EUR$4,850USD£3,788GBP
- Report
- August 2026
- 160 Pages
Global
From €3023EUR$3,320USD£2,593GBP
€3779EUR$4,150USD£3,241GBP

Opioid Use Disorder (OUD) is a type of addiction disorder that is characterized by the compulsive use of opioids, such as heroin, morphine, and prescription painkillers. OUD is a serious public health issue, with an estimated 2.1 million people in the United States suffering from the disorder. OUD is associated with a range of physical and psychological health problems, including an increased risk of overdose, infectious diseases, and mental health issues. Treatment for OUD typically involves a combination of medication-assisted treatment (MAT) and psychosocial interventions. MAT involves the use of medications, such as buprenorphine and methadone, to reduce cravings and withdrawal symptoms. Psychosocial interventions include cognitive-behavioral therapy, motivational interviewing, and 12-step programs.
Companies in the OUD market include Indivior, Alkermes, Orexo, and Braeburn Pharmaceuticals. Show Less Read more